RU2013121799A - Набор для претаргетинга, способ и агенты, применяемые в нем - Google Patents
Набор для претаргетинга, способ и агенты, применяемые в нем Download PDFInfo
- Publication number
- RU2013121799A RU2013121799A RU2013121799/15A RU2013121799A RU2013121799A RU 2013121799 A RU2013121799 A RU 2013121799A RU 2013121799/15 A RU2013121799/15 A RU 2013121799/15A RU 2013121799 A RU2013121799 A RU 2013121799A RU 2013121799 A RU2013121799 A RU 2013121799A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- aryl
- group
- independently
- bio
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
- A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0495—Pretargeting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Radiology & Medical Imaging (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nanotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10187619 | 2010-10-14 | ||
| EP10187619.1 | 2010-10-14 | ||
| PCT/IB2011/054481 WO2012049624A1 (en) | 2010-10-14 | 2011-10-11 | Pretargeting kit, method and agents used therein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2013121799A true RU2013121799A (ru) | 2014-11-20 |
Family
ID=43736149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013121799/15A RU2013121799A (ru) | 2010-10-14 | 2011-10-11 | Набор для претаргетинга, способ и агенты, применяемые в нем |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9463256B2 (enExample) |
| EP (1) | EP2627358B1 (enExample) |
| JP (2) | JP6063384B2 (enExample) |
| RU (1) | RU2013121799A (enExample) |
| WO (1) | WO2012049624A1 (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012049624A1 (en) * | 2010-10-14 | 2012-04-19 | Koninklijke Philips Electronics N.V. | Pretargeting kit, method and agents used therein |
| EP2522369A1 (en) * | 2011-05-09 | 2012-11-14 | Koninklijke Philips Electronics N.V. | Pretargeting kit, method and agents used therein |
| EP2709666B1 (en) * | 2011-05-16 | 2021-07-14 | Koninklijke Philips N.V. | Bio-orthogonal drug activation |
| US20150166596A1 (en) * | 2012-05-21 | 2015-06-18 | Agilent Technologies, Inc. | Retro Diels Alder Reaction as a Cleavable Linker in DNA/RNA Applications |
| US10927139B2 (en) | 2012-11-22 | 2021-02-23 | Tagworks Pharmaceuticals B.V. | Chemically cleavable group |
| WO2014081299A1 (en) * | 2012-11-22 | 2014-05-30 | Tagworks Pharmaceuticals B.V. | Activatable liposomes |
| WO2014081300A1 (en) * | 2012-11-22 | 2014-05-30 | Tagworks Pharmaceuticals B.V. | Channel protein activatable liposomes |
| US20150297741A1 (en) * | 2012-11-22 | 2015-10-22 | Tagworks Pharmaceuticals B.V. | Bio-orthogonal drug activation |
| US20150359913A1 (en) * | 2013-01-25 | 2015-12-17 | Memorial Sloan-Kettering Cancer Center | Tetrazines/trans-cyclooctenes in solid phase synthesis of labeled peptides |
| US9110230B2 (en) | 2013-05-07 | 2015-08-18 | Corning Incorporated | Scratch-resistant articles with retained optical properties |
| US9366784B2 (en) | 2013-05-07 | 2016-06-14 | Corning Incorporated | Low-color scratch-resistant articles with a multilayer optical film |
| EP3010486B1 (en) | 2013-06-19 | 2023-11-22 | The Regents of The University of California | Chemical structures for localized delivery of therapeutic agents |
| ES2694723T3 (es) | 2014-01-04 | 2018-12-26 | Craniovation, Inc. | Dispositivo para su uso en terapia fotodinámica |
| WO2015117235A1 (en) * | 2014-02-10 | 2015-08-13 | Mcmaster University | Targeted molecular imaging contrast agents |
| AU2015229014B2 (en) | 2014-03-14 | 2019-07-25 | The Regents Of The University Of California | TCO conjugates and methods for delivery of therapeutic agents |
| JP6787789B2 (ja) * | 2014-04-04 | 2020-11-18 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 詰め替え可能な薬物送達デバイスおよびその使用方法 |
| US11267973B2 (en) | 2014-05-12 | 2022-03-08 | Corning Incorporated | Durable anti-reflective articles |
| US9790593B2 (en) | 2014-08-01 | 2017-10-17 | Corning Incorporated | Scratch-resistant materials and articles including the same |
| WO2016025480A1 (en) | 2014-08-11 | 2016-02-18 | The General Hospital Corporation | Cyclooctenes for bioorthogonol reactions |
| CN108135857A (zh) | 2015-09-10 | 2018-06-08 | 沙思奇公司 | 生物正交组合物 |
| EP3770649A1 (en) | 2015-09-14 | 2021-01-27 | Corning Incorporated | High light transmission and scratch-resistant anti-reflective articles |
| EP3153155B1 (en) * | 2015-10-08 | 2021-03-03 | President and Fellows of Harvard College | Refillable drug delivery devices and methods of use thereof |
| US11617799B2 (en) * | 2016-06-27 | 2023-04-04 | Tagworks Pharmaceuticals B.V. | Cleavable tetrazine used in bio-orthogonal drug activation |
| AU2018250312C1 (en) | 2017-04-07 | 2024-08-22 | Tambo, Inc. | Bioorthogonal compositions |
| US11560384B2 (en) | 2017-05-04 | 2023-01-24 | University Of Utah Research Foundation | Benzonorbornadiene derivatives and reactions thereof |
| WO2018204872A2 (en) * | 2017-05-05 | 2018-11-08 | Fusion Pharmaceuticals Inc. | Igf-1r monoclonal antibodies and uses thereof |
| EP3651741A4 (en) | 2017-07-14 | 2021-04-21 | The Penn State Research Foundation | COMPOSITIONS AND METHODS OF TARGETED DELIVERY OF A THERAPEUTIC AND / OR DIAGNOSTIC SPECIES |
| GB201720769D0 (en) | 2017-12-13 | 2018-01-24 | Univ Of Northumbria At Newcastle | Pericyclic reactions |
| JP2021506842A (ja) | 2017-12-18 | 2021-02-22 | ヤンセン バイオテツク，インコーポレーテツド | ポリペプチドの放射性標識 |
| CA3099419A1 (en) | 2018-05-04 | 2019-11-07 | Tagworks Pharmaceuticals B.V. | Tetrazines for high click conjugation yield in vivo and high click release yield |
| AU2019262521B2 (en) | 2018-05-04 | 2024-04-18 | Tagworks Pharmaceuticals B.V. | Compounds comprising a linker for increasing transcyclooctene stability |
| KR102591065B1 (ko) | 2018-08-17 | 2023-10-19 | 코닝 인코포레이티드 | 얇고, 내구성 있는 반사-방지 구조를 갖는 무기산화물 물품 |
| JP7337174B2 (ja) | 2018-09-18 | 2023-09-01 | ニカング セラピューティクス， インコーポレイテッド | Ｓｒｃホモロジー－２ホスファターゼ阻害剤としての三置換ヘテロアリール誘導体 |
| CN113677397A (zh) | 2019-02-13 | 2021-11-19 | 阿尔菲斯医疗股份有限公司 | 无创声动力学治疗 |
| AU2020282737A1 (en) | 2019-05-29 | 2021-12-16 | Sonalasense, Inc. | Sonosensitization |
| WO2020256546A1 (en) | 2019-06-17 | 2020-12-24 | Tagworks Pharmaceuticals B.V. | Compounds for fast and efficient click release |
| CA3143924C (en) | 2019-06-17 | 2025-06-03 | Tagworks Pharmaceuticals B.V. | Agents that allow in vivo cleavage of markers linked to biomolecules |
| US12386101B2 (en) | 2020-07-09 | 2025-08-12 | Corning Incorporated | Textured region of a substrate to reduce specular reflectance incorporating surface features with an elliptical perimeter or segments thereof, and method of making the same |
| CA3185803A1 (en) | 2020-08-07 | 2022-02-10 | Vijay Agarwal | Ultrasound arrays for enhanced sonodynamic therapy for treating cancer |
| JP2023537066A (ja) | 2020-08-07 | 2023-08-30 | タンボ・インコーポレイテッド | トランス－シクロオクテン生体直交型薬剤並びに癌及び免疫療法における使用 |
| KR20230173150A (ko) | 2021-04-20 | 2023-12-26 | 테라파워, 엘엘씨 | Ac-225 생성용 티타니아 기반 발생기 |
| EP4108669A1 (en) * | 2021-06-24 | 2022-12-28 | Institute Of Organic Chemistry And Biochemistry As CR, V.V.I. | Carbohydrate derivatives and kits for cell surface labeling |
| WO2023244185A1 (en) * | 2022-06-13 | 2023-12-21 | Fikrettin Sahin | Use of lutetium salt compounds for antiviral effect |
| CN122138843A (zh) * | 2023-09-15 | 2026-06-02 | 坦博公司 | 用于有效载荷的体内靶向递送的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4741900A (en) | 1982-11-16 | 1988-05-03 | Cytogen Corporation | Antibody-metal ion complexes |
| US5326856A (en) | 1992-04-09 | 1994-07-05 | Cytogen Corporation | Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding |
| EP2026840A2 (en) * | 2005-10-04 | 2009-02-25 | Koninklijke Philips Electronics N.V. | Targeted imaging and/or therapy using the [3+2]-azide-alkyne cycloaddition |
| CN102271712B (zh) * | 2008-10-31 | 2015-11-25 | 通用医疗公司 | 用于将物质递送至生物靶标的组合物和方法 |
| WO2010119389A2 (en) | 2009-04-16 | 2010-10-21 | Koninklijke Philips Electronics N.V. | Pretargeting kit, method and agents used therein |
| WO2012049624A1 (en) * | 2010-10-14 | 2012-04-19 | Koninklijke Philips Electronics N.V. | Pretargeting kit, method and agents used therein |
| US10927139B2 (en) * | 2012-11-22 | 2021-02-23 | Tagworks Pharmaceuticals B.V. | Chemically cleavable group |
-
2011
- 2011-10-11 WO PCT/IB2011/054481 patent/WO2012049624A1/en not_active Ceased
- 2011-10-11 US US13/877,725 patent/US9463256B2/en active Active
- 2011-10-11 EP EP11776566.9A patent/EP2627358B1/en active Active
- 2011-10-11 RU RU2013121799/15A patent/RU2013121799A/ru unknown
- 2011-10-11 JP JP2013533311A patent/JP6063384B2/ja active Active
-
2016
- 2016-07-12 JP JP2016137224A patent/JP6368745B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2627358B1 (en) | 2024-03-27 |
| JP6368745B2 (ja) | 2018-08-01 |
| JP2014506869A (ja) | 2014-03-20 |
| US9463256B2 (en) | 2016-10-11 |
| EP2627358C0 (en) | 2024-03-27 |
| WO2012049624A1 (en) | 2012-04-19 |
| JP2016193934A (ja) | 2016-11-17 |
| CN103269721A (zh) | 2013-08-28 |
| EP2627358A1 (en) | 2013-08-21 |
| US20130189184A1 (en) | 2013-07-25 |
| JP6063384B2 (ja) | 2017-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016193934A5 (enExample) | ||
| JP2014518861A5 (enExample) | ||
| RU2013133813A (ru) | Средства для выведения биомолекул из кровотока | |
| RU2011146322A (ru) | Набор для предварительного придания направленности действия, способ и средства, применяемые в нем | |
| KR101931382B1 (ko) | 토륨 방사성 핵종 및 히드록시피리디논 함유 리간드를 포함하는 표적화된 알파-입자 방출 복합체 | |
| EP2357166B1 (en) | Auto magnetic metal salen complex compound | |
| PT92619B (pt) | Processo para a preparacao de complexos do acido aminofosfonico e de formulacoes com base no referido acido | |
| JP5781007B2 (ja) | ホスホルアミデートアルキル化剤プロドラッグ | |
| CA3171183A1 (en) | Fap-targeted radiopharmaceuticals and imaging agents, and uses related thereto | |
| JP5421114B2 (ja) | 低酸素症選択性の弱塩基性２−ニトロイミダゾール送達薬剤およびその使用方法 | |
| US20050238578A1 (en) | High dose radionuclide complexes for bone marrow suppression | |
| NO20051108L (no) | Cytotoksiske midler som inneholder nye virksomme taksaner og terapeutisk anvendelse av disse | |
| RU2011107752A (ru) | Агенты, связывающиеся с psma, и их применение | |
| KR20080039508A (ko) | 인데노이소퀴놀리논 유사체 및 이의 사용 방법 | |
| AR068897A1 (es) | Inhibidores de proteasoma | |
| WO2008043911A3 (fr) | Complexes chelates dendritiques, leurs procedes de fabrication et compositions pharmaceutiques les contenant | |
| JP2016504325A (ja) | 放射線と組み合わせて使用するための放射線増感剤化合物 | |
| US20040067924A1 (en) | Actinium-225 complexes and conjugates for targeted radiotherapy | |
| WO2001085736A1 (en) | Porphyrin-based neutron capture agents for cancer therapy | |
| Vincent et al. | Late intensification with high-dose melphalan and autologous bone marrow support in breast cancer patients responding to conventional chemotherapy | |
| ES2743276T3 (es) | Derivados de ácido hidroxibisfosfónico bifuncionales | |
| AU2017283653C1 (en) | Porphyrin compounds and compositions useful for treating cancer | |
| RU2014132184A (ru) | Калмангафодипир, новое химическое соединение и другие смешанные комплексные соединения с металлами, способы получения, композиции и способы лечения | |
| SG145570A1 (en) | 4-æ7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents | |
| El-Mabhouh et al. | Preclinical investigations of drug and radionuclide conjugates of bisphosphonates for the treatment of metastatic bone cancer |